Frontier mental health research: psychedelics & drug studies

Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.

3 papers

Decarboxylation Study of Acidic Cannabinoids: A Novel Approach Using Ultra-High-Performance Supercritical Fluid Chromatography/Photodiode Array-Mass Spectrometry

Mei Wang, Yan-Hong Wang, Bharathi Avula, Mohamed M Radwan, Amira S Wanas, John van Antwerp, et al.
PubMed Central (PMC) Summary & key facts 2016 258 citations

The study heated Cannabis sativa extracts at 80, 95, 110, 130, and 145 °C for up to 60 minutes and measured acidic and neutral cannabinoids with an advanced UHPSFC/PDA‑MS lab method. Concentrations changed in an exponential way, which fits a first‑order (or pseudo‑first‑order) reaction model. The team calculated rate constants…

Cannabis and Cannabinoid Research Forensic Toxicology and Drug Analysis Psychedelics and Drug Studies

Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and Two

John M McPartland, Christa MacDonald, Michelle Young, Phillip S Grant, Daniel P Furkert, Michelle Glass
PubMed Central (PMC) Summary & key facts 2017 69 citations

This lab study tested how the cannabis compound THCA-A binds to the two main cannabinoid receptors (CB1 and CB2). The THCA-A sample was found to contain 2% THC, and THCA-A showed only very weak binding and little or no effect at these receptors. The authors say some of the small…

Cannabis and Cannabinoid Research GABA and Rice Research Neurotransmitter Receptor Influence on Behavior

Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019

Kimberly G. Wagoner, Allison J. Lazard, E. Alfonso Romero‐Sandoval, Beth A. Reboussin

The study examined 39 FDA Warning Letters about CBD products issued from 2015 to 2019. It found most violations were online (websites and social media) and that nearly all letters (97%) cited companies marketing CBD as an unapproved drug. The letters also showed widespread claims that CBD could treat many…

Alcohol Consumption and Health Effects Cannabis and Cannabinoid Research Psychedelics and Drug Studies
Summaries and links are for general information and education only. They are not a substitute for reading the original publication or for professional medical, legal, or other advice. Always refer to the linked source for the full study.